Soligenix Inc (SNGX) - Financial and Strategic SWOT Analysis Review

September 2021 | 55 pages | ID: S38783FE0CDEN
GlobalData

Abstracts

Soligenix Inc (SNGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development and commercialization of products for the treatment of rare diseases and unmet medical needs. It develops specialized biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymphoma, pediatric Crohn's disease, oral mucositis and acute radiation enteritis. It develops proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the treatment of gastrointestinal disorders that are characterized by high inflammation. The company has active development programs for RiVax, a ricin toxin vaccine; and SGX943 for infectious disease. These vaccine programs are supported by ThermoVax, a heat stabilization technology. Soligenix is headquartered in Princeton, New Jersey, the US.

Soligenix Inc Key Recent Developments

Aug 13,2021: Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
May 17,2021: Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results
Apr 13,2021: Soligenix Announces Presentations at Prominent Scientific Conferences
Mar 30,2021: Soligenix Announces Recent Accomplishments and Year-End 2020 Financial Results
Mar 09,2021: Soligenix to receive $865,000 in non-dilutive funding through New Jersey technology business tax certificate transfer program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Soligenix Inc - Key Facts
Soligenix Inc - Key Employees
Soligenix Inc - Key Employee Biographies
Soligenix Inc - Major Products and Services
Soligenix Inc - History
Soligenix Inc - Company Statement
Soligenix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Soligenix Inc - Business Description
Business Segment: Public Health Solutions Segment
Overview
Performance
Business Segment: Specialized BioTherapeutics Segment
Overview
Performance
Soligenix Inc - Corporate Strategy
Soligenix Inc - SWOT Analysis
SWOT Analysis - Overview
Soligenix Inc - Strengths
Soligenix Inc - Weaknesses
Soligenix Inc - Opportunities
Soligenix Inc - Threats
Soligenix Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Soligenix Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 13, 2021: Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
May 17, 2021: Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results
Apr 13, 2021: Soligenix Announces Presentations at Prominent Scientific Conferences
Mar 30, 2021: Soligenix Announces Recent Accomplishments and Year-End 2020 Financial Results
Mar 09, 2021: Soligenix to receive $865,000 in non-dilutive funding through New Jersey technology business tax certificate transfer program
Feb 11, 2021: Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
Nov 12, 2020: Soligenix announces recent accomplishments and third quarter 2020 financial results
Sep 15, 2020: Soligenix announces publication demonstrating thermostabilization of filovirus vaccine antigens
Aug 14, 2020: Soligenix announces recent accomplishments and second quarter 2020 financial results
Jul 20, 2020: Soligenix issues corporate update - highlights important catalysts for second half of 2020

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Soligenix Inc, Key Facts
Soligenix Inc, Key Employees
Soligenix Inc, Key Employee Biographies
Soligenix Inc, Major Products and Services
Soligenix Inc, History
Soligenix Inc, Subsidiaries
Soligenix Inc, Key Competitors
Soligenix Inc, Ratios based on current share price
Soligenix Inc, Annual Ratios
Soligenix Inc, Annual Ratios (Cont...1)
Soligenix Inc, Interim Ratios
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Soligenix Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Soligenix Inc, Performance Chart (2016 - 2020)
Soligenix Inc, Ratio Charts
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Soligenix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021